Search research articles
Contact Us
Filters
Showing results (31-40 of 246) with videos related to
Page
of 25
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2007
Synthesis and antiproliferative activity of thiazolidine analogs for melanoma
Wei Li, Yan Lu, Zhao Wang, et al.
Journal of Neuroinflammation
|
August 1, 2013
Compound 49b protects against blast-induced retinal injury
Youde Jiang, Li Liu, Jayaprakash Pagadala, et al.
Bioconjugate Chemistry
|
September 14, 2007
Site-specific delivery of oligonucleotides to hepatocytes after systemic administration
Lin Zhu, Zhaoyang Ye, Kun Cheng, et al.
Steroids
|
August 7, 2024
Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics
Wendy Effah, Marjana Khalil, Dong-Jin Hwang, et al.
Molecules (Basel, Switzerland)
|
August 2, 2017
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Hao Chen, Zongtao Lin, Kinsie E Arnst, et al.
Pharmaceutical Research
|
March 28, 2012
Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer
Michael Danquah, Charles B Duke, Renukadevi Patil, et al.
Pharmaceutical Research
|
May 6, 2009
Micellar delivery of bicalutamide and embelin for treating prostate cancer
Michael Danquah, Feng Li, Charles B Duke, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 2005
The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators
Juhyun Kim, Di Wu, Dong Jin Hwang, et al.
Medicinal Research Reviews
|
October 16, 2008
Recent and emerging anti-diabetes targets
Michael L Mohler, Yali He, Zhongzhi Wu, et al.
Expert Opinion on Therapeutic Patents
|
February 11, 2010
Dissociated non-steroidal glucocorticoids: tuning out untoward effects
Michael L Mohler, Yali He, Zhongzhi Wu, et al.
Page
of 25
Search research articles
Search
Showing results (31-40 of 246) with videos related to
Sort By:
Page
of 25
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2007
Synthesis and antiproliferative activity of thiazolidine analogs for melanoma
Wei Li, Yan Lu, Zhao Wang, et al.
Journal of Neuroinflammation
|
August 1, 2013
Compound 49b protects against blast-induced retinal injury
Youde Jiang, Li Liu, Jayaprakash Pagadala, et al.
Bioconjugate Chemistry
|
September 14, 2007
Site-specific delivery of oligonucleotides to hepatocytes after systemic administration
Lin Zhu, Zhaoyang Ye, Kun Cheng, et al.
Steroids
|
August 7, 2024
Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics
Wendy Effah, Marjana Khalil, Dong-Jin Hwang, et al.
Molecules (Basel, Switzerland)
|
August 2, 2017
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Hao Chen, Zongtao Lin, Kinsie E Arnst, et al.
Pharmaceutical Research
|
March 28, 2012
Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer
Michael Danquah, Charles B Duke, Renukadevi Patil, et al.
Pharmaceutical Research
|
May 6, 2009
Micellar delivery of bicalutamide and embelin for treating prostate cancer
Michael Danquah, Feng Li, Charles B Duke, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 2005
The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators
Juhyun Kim, Di Wu, Dong Jin Hwang, et al.
Medicinal Research Reviews
|
October 16, 2008
Recent and emerging anti-diabetes targets
Michael L Mohler, Yali He, Zhongzhi Wu, et al.
Expert Opinion on Therapeutic Patents
|
February 11, 2010
Dissociated non-steroidal glucocorticoids: tuning out untoward effects
Michael L Mohler, Yali He, Zhongzhi Wu, et al.
Page
of 25